HEMOGLOBIN SELF-TEST INSTRUMENT - ANVISA Registration 82202950021
Access comprehensive regulatory information for HEMOGLOBIN SELF-TEST INSTRUMENT in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82202950021 and manufactured by MICO BIOMED CO., LTD.. The registration is held by MICO BIOMED DO BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
82202950021
25351955540202459
40749573000137
Company Information
Dates and Status
Mar 04, 2024
VIGENTE
09/18/2025 19:00:01
Hemoglobin Self-Test
Tira de teste de Hemoglobina VERI-Q MHS-3
MICO BIOMED CO., LTD.
82202950020
Mar 04, 2024
HEMOGLOBIN
Tira de teste de Hemoglobina VERI-Q MHS-2
MICO BIOMED CO., LTD.
82202950016
Oct 30, 2023
HEMOGLOBIN
Dispositivo de Controle da hemoglobina (Hb) Mission® Plus
ACON LABORATORIES, INC.
81327670103
May 20, 2019
HEMOGLOBIN
Solução Controle de Hemoglobina VERI-Q MULTI (MHCS-1)
MICO BIOMED CO., LTD.
82202950025
Jan 27, 2025
SELF-TEST INSTRUMENT FOR GLYCATED HEMOGLOBIN
Analisador A1CNOW® SELF CHECK
POLYMER TECHNOLOGY SYSTEMS, INC.
10230730148
Sep 30, 2021